drugset / Trial / NCT06739382

Management of Ventilation Acquired Pneumonia Caused by Pseudomonas and Acinetobacter Organisms in a Pediatric Center

NCT06739382

Phase 3 Completed 64 enrolled Beni-Suef University Cairo University · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to determine the most effective empirical therapy of antibiotics for better ventilator-associated pneumonia control. The main question it aims to answer is: • Which is better for clinical response single or combination empiric antibiotic therapies ?

Timeline

Start
2021-01-01
Primary completion
2021-12-01
Completion
2022-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Amikacin Small molecule
Subject Ertapenem Small molecule
Subject Meropenem Small molecule
Subject Polymyxin Unknown
Subject Tigecycline Small molecule